Michl M - Search Results

1

Prediction of ⁹⁰Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests.

Ingrisch M, Schöppe F, Paprottka K, Fabritius M, Strobl FF, De Toni EN, Ilhan H, Todica A, Michl M, Paprottka PM. Ingrisch M, et al. Among authors: michl m. J Nucl Med. 2018 May;59(5):769-773. doi: 10.2967/jnumed.117.200758. Epub 2017 Nov 16. J Nucl Med. 2018. PMID: 29146692 Free article.

2

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.

Haug AR, Tiega Donfack BP, Trumm C, Zech CJ, Michl M, Laubender RP, Uebleis C, Bartenstein P, Heinemann V, Hacker M. Haug AR, et al. Among authors: michl m. J Nucl Med. 2012 Mar;53(3):371-7. doi: 10.2967/jnumed.111.096230. Epub 2012 Feb 13. J Nucl Med. 2012. PMID: 22331219 Free article.

3

Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors.

Michl M, Haug AR, Jakobs TF, Paprottka P, Hoffmann RT, Bartenstein P, Boeck S, Haas M, Laubender RP, Heinemann V. Michl M, et al. Oncology. 2014;86(1):24-32. doi: 10.1159/000355821. Epub 2013 Dec 21. Oncology. 2014. PMID: 24401529

4

Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.

Michl M, Lehner S, Paprottka PM, Ilhan H, Bartenstein P, Heinemann V, Boeck S, Albert NL, Fendler WP. Michl M, et al. J Nucl Med. 2016 Mar;57(3):355-60. doi: 10.2967/jnumed.115.165613. Epub 2015 Nov 25. J Nucl Med. 2016. PMID: 26609176 Free article.

5

Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.

Fendler WP, Lechner H, Todica A, Paprottka KJ, Paprottka PM, Jakobs TF, Michl M, Bartenstein P, Lehner S, Haug AR. Fendler WP, et al. Among authors: michl m. J Nucl Med. 2016 Apr;57(4):517-23. doi: 10.2967/jnumed.115.165050. Epub 2016 Jan 7. J Nucl Med. 2016. PMID: 26742710 Free article.

6

Evaluation of Visualization Using a 50/50 (Contrast Media/Glucose 5% Solution) Technique for Radioembolization as an Alternative to a Standard Sandwich Technique.

Paprottka KJ, Todica A, Ilhan H, Rübenthaler J, Schoeppe F, Michl M, Heinemann V, Bartenstein P, Reiser MF, Paprottka PM. Paprottka KJ, et al. Among authors: michl m. Cardiovasc Intervent Radiol. 2017 Nov;40(11):1740-1747. doi: 10.1007/s00270-017-1712-3. Epub 2017 Jun 5. Cardiovasc Intervent Radiol. 2017. PMID: 28584948

7

Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma-An Evaluation of Predictors.

Paprottka KJ, Galiè F, Ingrisch M, Geith T, Ilhan H, Todica A, Michl M, Nadjiri J, Paprottka PM. Paprottka KJ, et al. Among authors: michl m. Cancers (Basel). 2021 Oct 27;13(21):5399. doi: 10.3390/cancers13215399. Cancers (Basel). 2021. PMID: 34771563 Free PMC article.

8

Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy.

Michl M, Koch J, Laubender RP, Modest DP, Giessen C, Schulz Ch, Heinemann V. Michl M, et al. Tumour Biol. 2014 Oct;35(10):10121-7. doi: 10.1007/s13277-014-2280-7. Epub 2014 Jul 15. Tumour Biol. 2014. PMID: 25023402

9

Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.

Michl M, Thurmaier J, Schubert-Fritschle G, Wiedemann M, Laubender RP, Nüssler NC, Ruppert R, Kleeff J, Schepp W, Reuter C, Löhe F, Karthaus M, Neumann J, Kirchner T, Engel J, Heinemann V. Michl M, et al. Clin Colorectal Cancer. 2015 Dec;14(4):281-90. doi: 10.1016/j.clcc.2015.05.009. Epub 2015 Jun 6. Clin Colorectal Cancer. 2015. PMID: 26123495

10

Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels.

Stintzing S, Fischhaber D, Mook C, Modest DP, Giessen C, Schulz C, Haas M, Boeck S, Michl M, Stemmler J, Laubender RP, Heinemann V. Stintzing S, et al. Among authors: michl m. Anticancer Drugs. 2013 Oct;24(9):969-74. doi: 10.1097/CAD.0b013e32836411bc. Anticancer Drugs. 2013. PMID: 23863616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters